Castle Rock Hormone Health (CRHH) announced a strategic partnership with Franchise Sidekick to support national franchise expansion. The initiative aims to develop 100 to 250 new clinics in 2026, building toward a long-term goal of 1,500 clinics over the next five years. CRHH currently operates across the East Coast, Midwest, and Rocky Mountain region and has served more than 10,000 patients nationwide to date.
CRHH says its franchise model is built around standardized clinical and operational systems designed for replication across multiple locations. Clinics provide hormone therapy, medically guided weight management, and longevity services including peptides and IV offerings through a cash-pay structure intended to reduce the administrative complexity tied to traditional insurance billing.
According to CRHH, its clinical protocols were developed under Dr. Lee Moorer, Co-Founder and CMO, with an emphasis on consistency, monitoring, and ethical standards. The recurring care model uses ongoing laboratory review and continuous patient monitoring to support long-term optimization of metabolic, cognitive, and physical performance. Although traditionally associated with low testosterone and menopausal care, the company says its patient base now includes patients focused on longevity, prevention, and sustained performance.
“Responsible healthcare expansion requires strong infrastructure, clinical governance, and disciplined execution,” said Christopher Stolzman, CEO of Castle Rock Hormone Health. “Our collaboration with Franchise Sidekick supports sustainable national growth.”
The partnership is intended to strengthen franchise development and operational support as the company moves into additional markets.
“Operational consistency and franchisee support are critical when scaling healthcare concepts,” said Tyler Altenhofen, Chief Growth Officer and Co-Founder of Franchise Sidekick. “CRHH demonstrates strong alignment across clinical standards and operational systems.”
